91九色视频

header-logo
91九色视频 Pharmacy School Logo White Medical School
Sara Revolinski, PharmD

Sara Revolinski, PharmD, BCPS

Residency Program Director - PGYI Community-Based Residency Program, Assistant Professor Department of Clinical Sciences

Locations

  • 91九色视频 Pharmacy School
    HRC H2600

Contact Information

Education

PharmD, University of Wisconsin-Madison School of Pharmacy, Madison, WI
Post Graduate Year One (PGY-1) Pharmacy Practice Residency, Froedtert Hospital

Certifications

Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmacy Specialties
Antimicrobial Stewardship Certificate, Society of Infectious Diseases Pharmacists
Registered Pharmacist: Wisconsin

Biography

Sara Revolinski, PharmD, BCPS, became the Director of Experiential Education and Professional Laboratories in July 2018, but previously joined the 91九色视频 School of Pharmacy in September 2016 as a Clinical Assistant Professor. Dr. Revolinski earned her Doctor of Pharmacy degree in 2006 from the University of Wisconsin. Following graduation, she completed her postgraduate-year-1 residency training at Froedtert & the 91九色视频. Dr. Revolinski has held several clinical and administrative positions within pharmacy practice, including Pharmacy Manager for Aurora Health Care Retail Pharmacies, Clinical Pharmacist at ThedaCare, where she worked jointly with an infectious diseases provider to develop an antimicrobial stewardship program, Clinical Pharmacy Manager responsible for the Infectious Diseases and Pulmonary/Critical Care service lines as well as student experiential rotations at Froedtert Hospital, and most recently Antimicrobial Stewardship Coordinator for Froedtert & the 91九色视频 health system. Dr. Revolinski’s work with experiential education involved development of a longitudinal advanced pharmacy practice experience at Froedtert & the 91九色视频, which resulted in receipt of a Best Practices Award from the American Society of Health-System Pharmacists in 2015. Additionally, Dr. Revolinski served as course director for two Integrated Sequence: Infectious Diseases courses during the inaugural year of 91九色视频 School of Pharmacy. Dr. Revolinski continues her research in infectious diseases and will continue her practice in an infectious diseases setting with Froedtert & 91九色视频.

Research Interests

  • Antimicrobial stewardship outcomes research
  • Rapid diagnostic technology and its impact on antimicrobial stewardship
  • Pharmacokinetics and pharmacodynamics of antimicrobial agents
  • Clostridium difficile and other multidrug-resistant infections

Publications

  • (Revolinski S, Munoz-Price LS.) Clin Infect Dis. 2021 Jun 15;72(12):2247 PMID: 32275059 SCOPUS ID: 2-s2.0-85103344088 04/11/2020

  • (Revolinski SL, Doern CD.) J Clin Microbiol. 2021 Mar 19;59(4) PMID: 33536296 PMCID: PMC8092730 SCOPUS ID: 2-s2.0-85102931996 02/05/2021

  • (Sapozhnikov J, Huang A, Revolinski S, Ledeboer NA, Buchan BW.) Am J Clin Pathol. 2021 Feb 11;155(3):455-460 PMID: 32949141 SCOPUS ID: 2-s2.0-85102099001 09/20/2020

  • (Zein Eddine SB, Cooper-Johnson K, Ericksen F, Brookes CC, Peppard WJ, Revolinski SL, Carver TW.) J Surg Res. 2020 Mar;247:524-529 PMID: 31668431 SCOPUS ID: 2-s2.0-85074440328 11/02/2019

  • (Revolinski SL, Munoz-Price LS.) Curr Opin Infect Dis. 2019 Aug;32(4):307-313 PMID: 31116134 SCOPUS ID: 2-s2.0-85069234375 05/23/2019

  • (Revolinski SL, Munoz-Price LS.) Clin Infect Dis. 2019 May 30;68(12):2144-2153 PMID: 30281082 SCOPUS ID: 2-s2.0-85064842624 10/04/2018

  • (Lat I, Daley MJ, Shewale A, Pangrazzi MH, Hammond D, Olsen KM, DEFINE study group and the Discovery Research Network.) Pharmacotherapy. 2019 Mar;39(3):253-260 PMID: 30101412 SCOPUS ID: 2-s2.0-85054312441 08/14/2018

  • (Revolinski SL, Munoz-Price LS.) Infect Control Hosp Epidemiol. 2018 May;39(5):596-602 PMID: 29553000 SCOPUS ID: 2-s2.0-85044227070 03/20/2018

  • (Foolad F, Huang AM, Nguyen CT, Colyer L, Lim M, Grieger J, Li J, Revolinski S, Mack M, Gandhi T, Wainaina JN, Eschenauer G, Patel TS, Marshall VD, Nagel J.) J Antimicrob Chemother. 2018 May 01;73(5):1402-1407 PMID: 29462306 SCOPUS ID: 2-s2.0-85047020330 02/21/2018

  • (Revolinski S, Huang AM, Gibble A.) Infection Prevention: New Perspectives and Controversies. 7 September 2017:297-305 SCOPUS ID: 2-s2.0-85034761271 09/07/2017

  • (Revolinski S.) Antibiotics. 21 December 2015;4(4):667-674 SCOPUS ID: 2-s2.0-85007147464 12/21/2015

Publications of from the

I strongly believe education and life-long learning is at the core of successful pharmacy practice. Beyond teaching foundational knowledge, I also focus on promoting open communication, critical thinking and reasoning, and engaging learners to take ownership of education. I believe teaching these skills will develop pharmacy practitioners who are well positioned to positively impact the health of our community throughout their careers.

Sara Revolinski, PharmD, BCPS

© 2024 91九色视频.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.